Issn Print: 1043-6618
Publication Date: 2017/10/01
Value-Based pricing and the end of pharmaceutical pricing as we know it? A case study on sorafenib and axitinib
Author Information: Health Economics, European University, Master in Public Health, Dep. of Health Sciences, School of Sciences, 6, Diogenis Str Nicosia, CY 2404, Cyprus
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.